SECsense Logo

Crinetics Pharmaceuticals 8-K Report: Key Event Filing on February 21, 2025

$CRNX
Form 8-K
Filed on: 2025-02-24
Source
Crinetics Pharmaceuticals 8-K Report: Key Event Filing on February 21, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: February 21, 2025
  • Entity: Crinetics Pharmaceuticals, Inc.
  • CIK: 0001658247
  • SEC File Number: 001-38583
  1. Company Information:
  • State of Incorporation: Delaware (DE)
  • EIN: 26-3744114
  • Address: 6055 Lusk Boulevard, San Diego, CA 92121
  • Phone Number: (858) 450-6464
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: CRNX
  • Exchange: NASDAQ
  1. Reporting Context:
  • The report is filed for a specific event as indicated by the 8-K form, which is typically used to disclose significant events that shareholders should be aware of.
  1. Period:
  • Start Date: February 21, 2025
  • End Date: February 21, 2025
  • This indicates that the report covers events occurring on the same day it was filed.

This summary provides essential information about the company's filing and basic corporate details, which are crucial for investors and stakeholders interested in Crinetics Pharmaceuticals, Inc.